GlaxoSmithKline And Aids Drugs In South Africa (A): The Fight For Lives And Profits Harvard Case Solution & Analysis

IMD-3-1496 © 2005
Yaziji, Michael; Lindblom, Anna

At the very same time other NGOs likewise went after GSK. For GSK the circumstance in South Africa was exceptionally fragile. Battling the NGOs might bring unfavorable promotion and; eventually; be self-defeating.; million of individuals were passing away of AIDS in South Africa.

Subjects: NGOs; Non-market competition; Ethics;Pharmaceutical; AIDS; Patents
Settings: South Africa; Pharmaceutical; Largest pharmaceutical company in the world; >100;000 employees; 2001-2004

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.